Trials / Active Not Recruiting
Active Not RecruitingNCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- Female
- Age
- 16 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the risk of pregnancy and infant outcomes among women with migraine exposed to rimegepant during pregnancy and in two rimegepant unexposed comparator groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rimegepant | Rimegepant 75mg |
| DRUG | Various | Various |
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2021-12-15
- Primary completion
- 2028-04-17
- Completion
- 2028-04-17
- First posted
- 2022-01-20
- Last updated
- 2026-01-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05198245. Inclusion in this directory is not an endorsement.